Riskpilot← Back to searchSign inGet full accessBYGMED3 ApS
APSActiveCVR 30499867Egelundvej 30Joinery installation · NACE 4332Est. 20071 employees
Revenue 2025
DKK 354K
-8% vs 2024
EBITDA margin
2.3%
-73% vs 2024
Equity ratio
64.3%
Financial strength
Net profit 2025
DKK 5K
-78% vs 2024
| Revenue | DKK 354K | -8% |
| EBITDA | DKK 8K | -73% |
| Net profit | DKK 5K | -78% |
| Total assets | DKK 369K | -8% |
| Equity | DKK 237K | +2% |
| Employees | 1 | — |
Legal name
BYGMED3 ApS
CVR number
30499867
Legal form
Anpartsselskab
NACE code
4332 · Joinery installation
Founded
12. april 2007
Share capital
DKK 135.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at drive tømrer- og anden entreprisevirksomhed efter direktionens skøn
Address
Egelundvej 30
Phone
+4524453033
Email
bygmed3@bygmed3.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 781 | 505 | 504 | 905 | 1.100 | 500 | 379 | 296 | 336 | 431 | 451 | 420 | 385 | 354 |
| Staff expenses | -666 | -423 | -433 | -886 | -1.029 | -491 | -335 | -282 | -307 | -351 | -366 | -349 | -355 | -346 |
| EBITDA | 115 | 81 | 71 | 19 | 71 | 8 | 44 | 14 | 29 | 80 | 85 | 71 | 30 | 8 |
| Depreciation & amort. | -10 | -15 | -6 | -6 | -6 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 105 | 66 | 65 | 13 | 65 | 8 | 44 | 14 | 29 | 80 | 85 | 71 | 30 | 8 |
| Net financials | -3 | -1 | -1 | -1 | -2 | -3 | -1 | -1 | -1 | -1 | -2 | -4 | 0 | -2 |
| Profit before tax | 102 | 65 | 64 | 12 | 63 | 5 | 43 | 13 | 29 | 79 | 83 | 67 | 30 | 6 |
| Tax | 27 | 16 | 16 | 3 | 14 | 1 | 8 | 3 | 6 | 18 | 18 | 15 | 7 | 1 |
| Net profit | 75 | 49 | 48 | 9 | 49 | 4 | 35 | 10 | 22 | 61 | 65 | 52 | 23 | 5 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 377 | 342 | 403 | 457 | 326 | 233 | 305 | 392 | 349 | 461 | 413 | 467 | 403 | 369 |
| Equity | 179 | 180 | 179 | 138 | 187 | 166 | 201 | 186 | 208 | 269 | 276 | 269 | 232 | 237 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 198 | 162 | 224 | 315 | 137 | 64 | 97 | 205 | 137 | 192 | 136 | 192 | 166 | 126 |
| Total debt | 198 | 162 | 224 | 315 | 137 | 64 | 97 | 205 | 137 | 192 | 136 | 192 | 166 | 126 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20122025
Equity ratio
64.3%
This company
38.2%
Market median
+68% vs market
20122025
Return on equity
2.2%
This company
18.4%
Market median
-88% vs market
20122025
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20122025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20122025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TB Management | Management | 2007 | — | — |
IL Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BYGMED3 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Brinck Harder | Management | 0 companies |
| Ivan Langmach Jacobsen | Management | 0 companies |